|
Expanded portfolio of syngeneic models
March 2017
SHARING OPTIONS:
Eurofins Pharma Discovery Services
Conduct immuno-oncology studies with our recently expanded portfolio of syngeneic murine models, which includes the following
tissue/organ types: breast, colon, kidney, leukemia, lung, melanoma and sarcoma. Study endpoints include standard efficacy, histopathology, immunophenotyping
with flow cytometry and biochemical analyses. Eurofins also has an extensive portfolio of xenograft models.
Eurofins Pharma Discovery Services
SEE US AT AACR BOOTH 2942
Back |
Home |
FAQs |
Search |
Submit News Release |
Site Map |
About Us |
Advertising |
Resources |
Contact Us |
Terms & Conditions |
Privacy Policy
|